Windham Venture Partners
Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical
Business Model:
Revenue: $8M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Windham Venture Partners Information
Geographic Data
Address: 1325 Avenue of the Americas
City: New York
State: NY
Zip: 10019
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical technology (devices and diagnostics) and digital health (the intersection of biology, genomics, and information technology). Windham seeks to invest in and partner with companies that are commercializing game-changing technologies to serve unmet needs in order to improve the lives of large numbers of patients and yield robust returns for its investors. For more information visit: www.windhamvp.com
Contact Phone:
+12127638525
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2019 | NeuSpera Medical | Series B | 12M |
| 5/2012 | Neotract | Series C | 37M |
| 1/2017 | Neotract | Venture Round | 12.8M |
| 1/2016 | DOTS | Series A | 10M |
| 9/2020 | Willow | Series C | 0 |
| 7/2014 | HelpAround Medical | Convertible Note | 610k |
| 6/2015 | Coravin | Series C | 13.6M |
| 1/2021 | Delfi Diagnostics | Series A | 0 |
| 1/2017 | Cartiva | Series E | 8.5M |
| 3/2023 | Clever Care Health Plan Inc. | Series C | 0 |
| 10/2014 | VytronUS | Series B | 31.6M |
| 4/2018 | Fore Biotherapeutics | Venture Round | 6M |
| 9/2020 | ControlRad | Series C | 12.3M |
| 8/2011 | MC10 | Series B | 2.5M |
| 10/2015 | Personal Genome Diagnostics | Series A | 21.4M |
| 2/2021 | Valera Health | Venture Round | 0 |
| 9/2014 | Ivantis | Series B | 25M |
| 5/2015 | Cartiva | Series D | 8.5M |
| 9/2009 | Neotract | Series B | 28.1M |
| 9/2022 | Upward Health | Series B | - |
| 1/2020 | HelpAround Medical | Series A | 6M |
| 2/2019 | Nuvaira | Equity | 79M |
| 6/2019 | SubjectWell | Series A | 10M |
| 1/2014 | Neotract | Venture Round | 50.6M |
| 10/2019 | Science Exchange | Equity | 20M |
| 10/2022 | Alto Neuroscience | Series B | 35M |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 8/2019 | Delfi Diagnostics | Seed Round | 5.5M |
| 5/2015 | ClarVista Medical | Series B | 0 |
| 10/2018 | Earlens | Series D | 0 |
| 10/2022 | Vergent Bioscience | Series B | 0 |
| 7/2022 | Delfi Diagnostics | Series B | 0 |
| 1/2014 | Welldoc | Series A | 20M |
| 11/2010 | Transactis | Series B | 7M |
| 10/2022 | SubjectWell | Series B | 35M |
| 1/2018 | NeuSpera Medical | Series B | 26M |
| 7/2021 | NeuSpera Medical | Series C | 65M |
| 6/2019 | andros | Series B | 14M |
| 9/2021 | Clever Care Health Plan Inc. | Series B | 71M |
| 12/2019 | ChromaCode | Series C | 0 |
| 8/2018 | MC10 | Venture Round | 0 |
| 3/2016 | Science Exchange | Series B | 25M |
| 10/2019 | Science Exchange | Debt Financing | - |
| 6/2017 | Earlens | Series C | 0 |
| 1/2018 | Personal Genome Diagnostics | Series B | 75M |
| 10/2022 | Valera Health | Venture Round | 0 |
| 11/2021 | Valera Health | Venture Round | 0 |
| 2/2021 | Personal Genome Diagnostics | Series C | 0 |
| 3/2021 | Upward Health | Venture Round | - |
| 6/2018 | Cureatr | Venture Round | 3M |
| 10/2018 | Nebula Genomics | Series A | 0 |
| 8/2019 | CVRx | Series G | 93M |
| 6/2015 | Cureatr | Series B | 0 |
| 12/2012 | MC10 | Series C | 10M |
| 1/2016 | GlySens | Series D | 20M |
| 4/2014 | Nuvaira | Series D | 42M |
| 4/2015 | Nuelle | Venture Round | 7.1M |
| 7/2022 | Delfi Diagnostics | Series B | 0 |
| 11/2021 | Valera Health | Venture Round | 0 |
| 9/2021 | Clever Care Health Plan Inc. | Series B | 0 |
| 7/2021 | NeuSpera Medical | Series C | 0 |
| 5/2021 | Alto Neuroscience | Series A | 0 |
| 3/2021 | Upward Health | Venture Round | - |
| 2/2021 | Personal Genome Diagnostics | Series C | 0 |
| 2/2021 | Valera Health | Venture Round | 0 |
| 1/2021 | Delfi Diagnostics | Series A | 0 |
| 9/2020 | Willow | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
